Vanda Pharmaceuticals | VNDA - Текущие обязательства

Биржевая цена
7.06
Изменение за день
-0.06 -0.84%
Ежемесячно
-13.59%
Ежегодный
46.47%
Q1 прогноз
6.91




Текущие обязательства Изменить Дата
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Anika Therapeutics USD 21.91M 2.82M 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Eli Lilly USD 35.23B 4.91B 2025-12
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Insmed USD 468.87M 51.66M 2025-12
J&J USD 54.13B 3.26B 2025-12
Lexicon Pharmaceuticals USD 20.87M 853K 2025-12
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
Merck USD 28.63B 2.59B 2025-09
Minerva Neurosciences USD 2.29M 381K 2025-12
Moderna USD 1.99B 306M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 3.76B 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12
Veracyte USD 59.94M 12.22M 2025-12